BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38060005)

  • 1. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
    Panchawagh S; Ravichandran N; Barman B; Nune A; Javaid M; Gracia-Ramos AE; Day J; Joshi M; Kuwana M; Saha S; Pande AR; Caballero-Uribe CV; Velikova T; Parodis I; Knitza J; Kadam E; Tan AL; Shinjo SK; Boro H; ; Aggarwal R; Agarwal V; Chatterjee T; Gupta L
    Rheumatol Int; 2024 Jan; 44(1):73-80. PubMed ID: 38060005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
    Hoff LS; Ravichandran N; Shinjo SK; Day J; Sen P; Junior JG; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Milchert M; Makol A; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Cansu DÜ; Traboco L; Wibowo SAK; Tehozol EAZ; Serrano JR; La Torre IG; Wincup C; Pauling JD; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
    Rheumatol Int; 2023 Jan; 43(1):47-58. PubMed ID: 36271958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
    Shumnalieva R; Ravichandran N; Hannah J; Javaid M; Darooka N; Roy D; Gonzalez DE; Velikova T; Milchert M; Kuwana M; Joshi M; Gracia-Ramos AE; Boyd P; Yaadav P; Cheng K; Kobert L; Cavagna L; Sen P; Day J; Makol A; Gutiérrez CET; Caballero-Uribe CV; Saha S; Parodis I; Dey D; Nikiphorou E; Distler O; Kadam E; Tan AL; Shinjo SK; Ziade N; Knitza J; Chinoy H; Aggarwal R; Agarwal V; Gupta L;
    Int J Rheum Dis; 2024 May; 27(5):e15178. PubMed ID: 38742751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.
    Ahmed S; Gupta L; Kuwana M; Pauling JD; Day J; Ravichandran N; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Wibowo SAK; ; Chinoy H; Aggarwal R; Agarwal V; Makol A
    Rheumatol Int; 2024 Jan; 44(1):89-97. PubMed ID: 37668836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
    Sen P; Ravichandran N; Nune A; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
    Rheumatology (Oxford); 2022 Dec; 62(1):65-76. PubMed ID: 35713499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.
    Chatterjee T; Ravichandran N; Nair N; Gracia-Ramos AE; Barman B; Sen P; Joshi M; Saha S; Nune A; Pande AKR; Velikova T; Parodis I; Tan AL; Shinjo SK; Boro H; Agarwal V; Aggarwal R; Gupta L;
    J Diabetes Investig; 2024 Jan; 15(1):131-138. PubMed ID: 37697820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between COVID-19 vaccines and development of chronic morbidities: a cross-sectional study in the Jordanian population.
    Al-Hawamdeh MI; Abu-Huwaij R; Astiti TA; Al-Debe'e AK; Abazeed OJ; Raees MA
    Curr Med Res Opin; 2024 Mar; 40(3):537-543. PubMed ID: 38193825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
    Panchawagh S; Bohdana D; Kuwana M; Yoshida A; Yomono K; Pauling JD; Makol A; Kadam E; Day J; Chatterjee T; Katchamart W; Goo PA; Nikiphorou E; Sen P; Dey D; Cavagna L; Gutiérrez CET; Agarwal V; Milchert M; Ziade N; Distler O; Group CS; Chinoy H; Aggarwal R; Gupta L; Agarwal V
    Rheumatol Int; 2023 Dec; 43(12):2211-2220. PubMed ID: 37712977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports.
    Alsudais AS; Alkanani RS; Fathi AB; Almuntashiri SS; Jamjoom JN; Alzhrani MA; Althubaiti A; Radi S
    BMC Endocr Disord; 2023 Aug; 23(1):164. PubMed ID: 37542216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study.
    Hoff LS; Naveen R; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
    Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38430474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
    Naveen R; Parodis I; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Nune A; Shinjo SK; Salim B; Ziade N; Velikova T; Edgar Gracia-Ramos A; Saavedra MA; Day J; Makol A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Nikiphorou E;
    Rheumatology (Oxford); 2023 Jul; 62(7):2366-2376. PubMed ID: 36315075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
    Naveen R; Thakare DR; Kuwana M; Pauling JD; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; ; Aggarwal R; Gupta L; Agarwal V; Makol A
    Rheumatol Int; 2023 Jul; 43(7):1265-1275. PubMed ID: 37000295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
    Sen P; R N; Houshmand N; Moghadam Kia S; Joshi M; Saha S; Jagtap K; Agarwal V; Nune A; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Day J; Chinoy H; ; Agarwal V; Aggarwal R; Gupta L
    Rheumatology (Oxford); 2023 Oct; 62(10):3291-3301. PubMed ID: 36734536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.
    Mohanasundaram K; Santhanam S; Natarajan R; Murugesan H; Nambi T; Chilikuri B; Nallasivan S
    Int J Rheum Dis; 2022 Sep; 25(9):1046-1052. PubMed ID: 35773944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys.
    Jagtap K; Naveen R; Day J; Sen P; Vaidya B; Nune A; Nikiphorou E; Tan AL; Agarwal V; Saha S; Shinjo SK; Ziade N; Joshi M; Velikova T; Milchert M; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
    Rheumatology (Oxford); 2023 Dec; 62(12):3838-3848. PubMed ID: 36961331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.
    Sen P; Gupta L; Lilleker JB; Aggarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Cagnotto G; Nune A; Distler O; Chinoy H; Aggarwal V; Aggarwal R;
    Rheumatol Int; 2022 Jan; 42(1):23-29. PubMed ID: 34779868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
    Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
    Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.
    Grignaschi S; Kim M; Zanframundo G; Ravichandran N; Lilleker JB; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Cavagna L; Agarwal V; Aggarwal R; Gupta L;
    Rheumatol Int; 2023 Sep; 43(9):1637-1649. PubMed ID: 37314497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination.
    Sprow G; Afarideh M; Dan J; Feng R; Keyes E; Grinnell M; Concha J; Werth VP
    Front Immunol; 2022; 13():899526. PubMed ID: 35693768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.